Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.

Pitout, 2008, Extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae: an emerging public‐health concern, Lancet Infect Dis, 8, 159, 10.1016/S1473-3099(08)70041-0

Cantón, 2008, Prevalence and spread of extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae in Europe, Clin Microbiol Infect, 14, 144, 10.1111/j.1469-0691.2007.01850.x

Tolun, 2004, Relationship between ciprofloxacin resistance and extended‐spectrum beta‐lactamase production in Escherichia coli and Klebsiella pneumoniae strains, Clin Microbiol Infect, 10, 72, 10.1111/j.1469-0691.2004.00723.x

Pagani, 1998, Comparative activity of piperacillin/tazobactam against clinical isolates of extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae, Chemotherapy, 44, 377, 10.1159/000007147

Spanu, 2002, Occurrence of extended‐spectrum beta‐lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta‐lactams and other antimicrobial drugs, Antimicrob Agents Chemother, 46, 196, 10.1128/AAC.46.1.196-202.2002

Gavin, 2006, Clinical correlation of the CLSI susceptibility breakpoint for piperacillin–tazobactam against extended‐spectrum beta‐lactamase‐producing Escherichia coli and Klebsiella species, Antimicrob Agents Chemother, 50, 2244, 10.1128/AAC.00381-05

Peterson, 2008, Antibiotic policy and prescribing strategies for therapy of extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae: the role of piperacillin–tazobactam, Clin Microbiol Infect, 14, 181, 10.1111/j.1469-0691.2007.01864.x

Jett, 1995, In vitro activities of various beta‐lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins, Antimicrob Agents Chemother, 39, 1187, 10.1128/AAC.39.5.1187

Leleu, 1994, Different ratios of the piperacillin–tazobactam combinations for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM‐3 extended‐spectrum beta‐lactamase, Antimicrob Agents Chemother, 38, 195, 10.1128/AAC.38.2.195

Segatore, 2004, Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta‐lactamase patterns including extended‐spectrum enzymes, Int J Antimicrob Agents, 23, 480, 10.1016/j.ijantimicag.2003.10.011

Thomson, 2001, Cefepime, piperacillin–tazobactam, and the inoculum effect in tests with extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae, Antimicrob Agents Chemother, 45, 3548, 10.1128/AAC.45.12.3548-3554.2001

Hernández, 2005, Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended‐spectrum beta‐lactamases, Antimicrob Agents Chemother, 49, 2122, 10.1128/AAC.49.5.2122-2125.2005

Clinical and Laboratory Standards Institute, 2006

National Committee for Clinical Laboratory Standards, 1999

Soriano, 1996, Correlation of pharmacodynamic parameters of five beta‐lactam antibiotics with therapeutic efficacies in an animal model, Antimicrob Agents Chemother, 40, 2686, 10.1128/AAC.40.12.2686

Goldstein, 1991, Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta‐lactamase inhibitor combinations, and the penicillin‐derived components of these combinations, Antimicrob Agents Chemother, 35, 560, 10.1128/AAC.35.3.560

Burgess, 2004, In vitro killing of parenteral beta‐lactams against standard and high inocula of extended‐spectrum beta‐lactamases and non‐ESBL producing Klebsiella pneumoniae, Diagn Microbiol Infect Dis, 49, 41, 10.1016/j.diagmicrobio.2003.11.007

Curtis, 1979, Affinities of penicillins and cephalosporins for the penicillin‐binding proteins of Escherichia coli K‐12 and their antibacterial activity, Antimicrob Agents Chemother, 16, 533, 10.1128/AAC.16.5.533

Mitsuyama, 1987, The mechanism of action of piperacillin‐analogues in vitro; effect of the carbon number at the N‐4 position of 2,3‐dioxopiperazine on the outer membrane permeability, stability to beta‐lactamase and binding affinity to penicillin‐binding proteins, J Antibiot (Tokyo), 40, 868, 10.7164/antibiotics.40.868

Sauvage, 2008, The penicillin‐binding proteins: structure and role in peptidoglycan biosynthesis, FEMS Microbiol Rev, 32, 234, 10.1111/j.1574-6976.2008.00105.x

Spratt, 1977, Binding of thienamycin and clavulanic acid to the penicillin‐binding proteins of Escherichia coli K‐12, Antimicrob Agents Chemother, 12, 406, 10.1128/AAC.12.3.406

Burgess, 2003, Clinical and microbiologic analysis of a hospital’s extended‐spectrum beta‐lactamase‐producing isolates over a 2‐year period, Pharmacotherapy, 23, 1232, 10.1592/phco.23.12.1232.32706

Paterson, 1999, Fatal infection due to extended‐spectrum beta‐lactamase‐producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis, Clin Infect Dis, 28, 683, 10.1086/517217

Zimhony, 2006, Endocarditis caused by extended‐spectrum beta‐lactamase‐producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin/tazobactam during treatment despite initial susceptibility, Antimicrob Agents Chemother, 50, 3179, 10.1128/AAC.00218-06